Contribution: Industrial Research Assistance Program – Contributions to Firms
Biodroga Neutraceuticals inc.
$246,500.00
Marine Lipids as Formulation Agents
EF 2018-19 · 2019-01-01
Résumé
The company will develop two nutraceutical products that will improve the absorption and bioavailability of curcumin and Coenzyme Q10.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Vaudreuil-Dorion|Vaudreuil-Dorion, Quebec, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
100524123
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Modifications
Chaque version de l'entente telle que publiée, de la plus ancienne à la plus récente, avec son total à cette version. Le montant ci-dessus est le plus récent.
| Modification | Date | Exercice financier | Total |
|---|---|---|---|
| 0 | 2019-01-01 | 2018-19 | $263,000.00 |
| 2 | 2019-01-01 | 2018-19 | $246,500.00 |
| 3 | 2019-01-01 | 2018-19 | $246,500.00 |
| 4 | 2019-01-01 | 2018-19 | $246,500.00 |
| 5 | 2019-01-01 | 2018-19 | $246,500.00 |
Tel que publié
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 182 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 182 jours.
Agreement End Date
2022-01-14
Agreement Number
922499
Agreement Start Date
2019-01-01
Agreement Title
Marine Lipids as Formulation Agents
Agreement Title (French)
Lipides marins comme agents de formulation
Agreement Type
Contribution
Agreement Value
$246,500.00
Amendment Date
2021-08-17
Amendment Number
5
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The company will develop two nutraceutical products that will improve the absorption and bioavailability of curcumin and Coenzyme Q10.
Description (French)
L'entreprise développera deux produits nutraceutiques, qui amélioreront l'absorption et la biodisponibilité de la curcumine et du coenzyme Q10.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vaudreuil--Soulanges
Federal Riding (French)
Vaudreuil--Soulanges
Federal Riding Number
24074
NAICS Code
311990
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
100524123
Recipient City
Vaudreuil-Dorion|Vaudreuil-Dorion
Recipient Country
CA
Recipient Legal Name
Biodroga Neutraceuticals inc.
Recipient Operating Name
Neptune Wellness
Recipient Postal Code
J7V 5V5
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2018-2019-Q4-922499
